Development and Validation of a New Nomogram Model for Predicting Acute Ischemic Stroke in Elderly Patients with Non-Valvular Atrial Fibrillation: A Single-Center Cross-Sectional Study

References

• January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104–132. doi:10.1016/j.jacc.2019.01.011
   PubMed Web of Science ®Google Scholar
• Khurshid S, Healey JS, McIntyre WF, Lubitz SA. Population-Based Screening for Atrial Fibrillation. Circulation Res. 2020;127(1):143–154. doi:10.1161/CIRCRESAHA.120.316341
   PubMed Web of Science ®Google Scholar
• Of the Report TW. Report on cardiovascular health and diseases in China 2021: an updated summary. J Geriatr Cardiol. 2023;20(6):399–430. doi:10.26599/1671-5411.2023.06.001
   PubMedGoogle Scholar
• Chung MK, Refaat M, Shen W-K, et al. Atrial Fibrillation: JACC Council Perspectives. J Am Coll Cardiol. 2020;75(14):1689–1713. doi:10.1016/j.jacc.2020.02.025
   PubMed Web of Science ®Google Scholar
• Baman JR, Passman RS. Atrial Fibrillation. JAMA. 2021;325(21):2218. doi:10.1001/jama.2020.23700
   PubMed Web of Science ®Google Scholar
• Kılıç R, Güzel T, Aktan A, Demir M, Arslan B, Ertaş F. The effect of treatment strategy on long-term follow-up results in patients with nonvalvular atrial fibrillation in Turkey: AFTER-2 subgroup analysis. Aging Clin Exp Res. 2023;35(8):1695–1704. doi:10.1007/s40520-023-02467-y
   PubMed Web of Science ®Google Scholar
• Ding M, Ebeling M, Ziegler L, Wennberg A, Modig K. Time trends in atrial fibrillation-related stroke during 2001-2020 in Sweden: a nationwide, observational study. Lancet Reg Health Eur. 2023;28:100596. doi:10.1016/j.lanepe.2023.100596
   PubMedGoogle Scholar
• Aktan A, Güzel T, Aslan B, et al. Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants: insight from the AFTER-2 trial. Kardiologia Polska. 2023;81(2):132–140. doi:10.33963/KP.a2022.0287
   PubMed Web of Science ®Google Scholar
• Güzel T, Aktan A, Kılıç R, et al. Oral Anticoagulant Use and Long-Term Follow-Up Results in Patients with Non-valvular Atrial Fibrillation in Turkey AFTER-2 Study. Anatol J Cardiol. 2022;26(7):567–576. doi:10.5152/AnatolJCardiol.2022.1597
   PubMed Web of Science ®Google Scholar
• Friberg L, Rosenqvist M, Lip GYH. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33(12):1500–1510. doi:10.1093/eurheartj/ehr488
   PubMed Web of Science ®Google Scholar
• Odum LE, Cochran KA, Aistrope DS, Snella KA. The CHADS₂versus the new CHA2DS2-VASc scoring systems for guiding antithrombotic treatment of patients with atrial fibrillation: review of the literature and recommendations for use. Pharmacotherapy. 2012;32(3):285–296. doi:10.1002/j.1875-9114.2012.01023.x
   PubMed Web of Science ®Google Scholar
• Quinn GR, Severdija ON, Chang Y, Singer DE. Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation. Circulation. 2017;135(3):208–219. doi:10.1161/CIRCULATIONAHA.116.024057
   PubMed Web of Science ®Google Scholar
• Borre ED, Goode A, Raitz G, et al. Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: a Systematic Review. Thromb Haemost. 2018;118(12):2171–2187. doi:10.1055/s-0038-1675400
   PubMed Web of Science ®Google Scholar
• Alkhouli M, Friedman PA. Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;74(24):3050–3065. doi:10.1016/j.jacc.2019.10.040
   PubMed Web of Science ®Google Scholar
• Kodani E, Akao M. Atrial fibrillation and stroke prevention: state of the art-epidemiology and pathophysiology: new risk factors, concepts and controversies. Eur Heart J Suppl. 2020;22(Suppl O):O1–O13. doi:10.1093/eurheartj/suaa176
   PubMed Web of Science ®Google Scholar
• Polymeris AA, Meinel TR, Oehler H, et al. Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. J Neurol Neurosurg Psychiatry. 2022;93(6):588–598. doi:10.1136/jnnp-2021-328391
   PubMedGoogle Scholar
• Hijazi Z, Lindbäck J, Alexander JH, et al. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J. 2016;37(20):1582–1590. doi:10.1093/eurheartj/ehw054
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• Jagadish PS, Kabra R. Stroke Risk in Atrial Fibrillation: beyond the CHA2DS2-VASc Score. Curr Cardiol Rep. 2019;21(9):95. doi:10.1007/s11886-019-1189-6
   PubMed Web of Science ®Google Scholar
• Fanola CL, Giugliano RP, Ruff CT, et al. A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial. Eur Heart J. 2017;38(12):888–896. doi:10.1093/eurheartj/ehw565
   PubMed Web of Science ®Google Scholar
• Pérez Cabeza AI, Bravo Marques R, Chinchurreta Capote PA, et al. TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillation. Clin Cardiol. 2018;41(9):1252–1258. doi:10.1002/clc.23035
   PubMed Web of Science ®Google Scholar
• Singer DE, Chang Y, Borowsky LH, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013;2(3):e000250. doi:10.1161/JAHA.113.000250
   PubMed Web of Science ®Google Scholar
• van den Ham HA, Klungel OH, Singer DE, Leufkens HGM, van Staa TP. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: results From a National Primary Care Database. J Am Coll Cardiol. 2015;66(17):1851–1859. doi:10.1016/j.jacc.2015.08.033
   PubMed Web of Science ®Google Scholar
• Deering TF. Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup. J Atr Fibrillation. 2017;9(6):1497. doi:10.4022/jafib.1497
   PubMedGoogle Scholar
• Saliba W, Barnett-Griness O, Elias M, Rennert G. Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study. J Thromb Haemost. 2015;13(11):1971–1979. doi:10.1111/jth.13006
   PubMed Web of Science ®Google Scholar
• Deng Y, Zhou F, Li Q, et al. Associations between neutrophil-lymphocyte ratio and monocyte to high-density lipoprotein ratio with left atrial spontaneous echo contrast or thrombus in patients with non-valvular atrial fibrillation. BMC Cardiovascular Disorders. 2023;23(1):234. doi:10.1186/s12872-023-03270-3
   PubMed Web of Science ®Google Scholar
• Yalcin M, Aparci M, Uz O, et al. Neutrophil-lymphocyte ratio may predict left atrial thrombus in patients with nonvalvular atrial fibrillation. Clin Appl Thromb Hemost. 2015;21(2):166–171. doi:10.1177/1076029613503398
   PubMed Web of Science ®Google Scholar
• Heijman J, Voigt N, Nattel S, Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circulation Res. 2014;114(9):1483–1499. doi:10.1161/CIRCRESAHA.114.302226
   PubMed Web of Science ®Google Scholar
• Y-F H, Chen Y-J, Lin Y-J, Chen S-A. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–243. doi:10.1038/nrcardio.2015.2
   PubMed Web of Science ®Google Scholar
• Hermann DM, Kleinschnitz C, Gunzer M. Implications of polymorphonuclear neutrophils for ischemic stroke and intracerebral hemorrhage: predictive value, pathophysiological consequences and utility as therapeutic target. J Neuroimmunol. 2018;321:138–143. doi:10.1016/j.jneuroim.2018.04.015
   PubMed Web of Science ®Google Scholar
• Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest. 2020;130(6):2777–2788. doi:10.1172/JCI135530
   PubMed Web of Science ®Google Scholar
• Liesz A, Zhou W, S-Y N, et al. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J Neurosci. 2013;33(44):17350–17362. doi:10.1523/JNEUROSCI.4901-12.2013
   PubMed Web of Science ®Google Scholar
• Fang Y-N, Tong M-S, Sung P-H, et al. Higher neutrophil counts and neutrophil-to-lymphocyte ratio predict prognostic outcomes in patients after non-atrial fibrillation-caused ischemic stroke. Biomed J. 2017;40(3):154–162. doi:10.1016/j.bj.2017.03.002
   PubMed Web of Science ®Google Scholar
• Hald EM, Løchen M-L, Lappegård J, et al. Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: the Tromsø Study. TH Open. 2020;4(3):e280–e7. doi:10.1055/s-0040-1716417
   PubMedGoogle Scholar
• Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007;115(2):135–143. doi:10.1016/j.ijcard.2006.04.026
   PubMed Web of Science ®Google Scholar
• Kurt M, Tanboga IH, Buyukkaya E, Karakas MF, Akçay AB, Sen N. Relation of red cell distribution width with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation. Clin Appl Thromb Hemost. 2014;20(7):687–692. doi:10.1177/1076029613478157
   PubMed Web of Science ®Google Scholar
• Ding WY, Protty MB, Davies IG, Lip GYH. Relationship between lipoproteins, thrombosis, and atrial fibrillation. Cardiovascular Res. 2022;118(3):716–731. doi:10.1093/cvr/cvab017
   PubMed Web of Science ®Google Scholar
• Chapman MJ, Huby T, Nigon F, Thillet J. Lipoprotein (a): implication in atherothrombosis. Atherosclerosis. 1994;110:S69–S75. doi:10.1016/0021-9150(94)05385-V
   PubMed Web of Science ®Google Scholar
• Igarashi Y, Yamaura M, Ito M, Inuzuka H, Ojima K, Aizawa Y. Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: a transesophageal echocardiographic study. Am Heart J. 1998;136(6):965–971. doi:10.1016/S0002-8703(98)70151-6
   PubMed Web of Science ®Google Scholar
• Mohammadi-Shemirani P, Chong M, Narula S, et al. Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: an Observational and Mendelian Randomization Study. J Am Coll Cardiol. 2022;79(16):1579–1590. doi:10.1016/j.jacc.2022.02.018
   PubMed Web of Science ®Google Scholar
• Chao T-F, Joung B, Takahashi Y, et al. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive Summary. Thromb Haemost. 2022;122(1):20–47. doi:10.1055/s-0041-1739411
   PubMedGoogle Scholar
• Wańkowicz P, Nowacki P, Gołąb-Janowska M. Atrial fibrillation risk factors in patients with ischemic stroke. Arch Med Sci. 2021;17(1):19–24. doi:10.5114/aoms.2019.84212
   PubMed Web of Science ®Google Scholar
• Lopez FL, Agarwal SK, Maclehose RF, et al. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol. 2012;5(1):155–162. doi:10.1161/CIRCEP.111.966804
   PubMed Web of Science ®Google Scholar
• Guan B, Li X, Xue W, et al. Blood lipid profiles and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Clin Lipidol. 2020;14(1):133–142.e3. doi:10.1016/j.jacl.2019.12.002
   PubMed Web of Science ®Google Scholar
• Zhang -X-X, Wei M, Shang L-X, et al. LDL-C/HDL-C is associated with ischaemic stroke in patients with non-valvular atrial fibrillation: a case-control study. Lipids Health Dis. 2020;19(1):217. doi:10.1186/s12944-020-01392-7
   PubMed Web of Science ®Google Scholar
• Suzuki M, Furuya K, Ozawa M, et al. Complex Aortic Arch Atherosclerosis in Acute Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation. J Atheroscler Thromb. 2021;28(7):776–785. doi:10.5551/jat.58339
   PubMed Web of Science ®Google Scholar